Literature DB >> 19016378

Traversal of human and animal trypanosomes across the blood-brain barrier.

Dennis J Grab1, Peter G E Kennedy.   

Abstract

The neurological complications of human African trypanosomiasis (HAT) in man caused by the unicellular protozoan parasites Trypanosoma brucei gambiense and T. b. rhodesiense are a consequence of the penetration of the blood-brain barrier (BBB) by trypanosomes that enter the central nervous system (CNS). Yet the mechanisms by which African trypanosomes cross the true BBB comprised of brain microvascular endothelial cells (BMECs) remain unclear. Human BBB models used to determine how African trypanosomes initially interact in vitro with the human BBB proper suggest that parasites cross the human BBB in part by generating Ca(2+) activation signals in human BMECs through the activity of parasite cysteine proteases. In vivo murine models of HAT have suggested additional mechanisms of BBB traversal by trypanosomes, with recent compelling evidence for the important role of interferon-gamma in facilitating this process. A clear understanding of how trypanosomes enter the CNS is critical for both understanding the neuropathogenesis of HAT and in developing more effective drug therapies for late-stage disease.

Entities:  

Mesh:

Year:  2008        PMID: 19016378     DOI: 10.1080/13550280802282934

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

1.  Molecular and cellular mechanisms for microbial entry into the CNS.

Authors:  J R Zhang; E Tuomanen
Journal:  J Neurovirol       Date:  1999-12       Impact factor: 2.643

Review 2.  Human African trypanosomiasis of the CNS: current issues and challenges.

Authors:  Peter G E Kennedy
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

3.  Endothelial cell activation in the presence of African trypanosomes.

Authors:  Murielle Girard; Stéphanie Giraud; Bertrand Courtioux; Marie-Odile Jauberteau-Marchan; Bernard Bouteille
Journal:  Mol Biochem Parasitol       Date:  2005-01       Impact factor: 1.759

Review 4.  The treatment of human African trypanosomiasis.

Authors:  J Pépin; F Milord
Journal:  Adv Parasitol       Date:  1994       Impact factor: 3.870

5.  Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model.

Authors:  C Mulenga; J D Mhlanga; K Kristensson; B Robertson
Journal:  Neuropathol Appl Neurobiol       Date:  2001-02       Impact factor: 8.090

6.  Meningoencephalitis in chronic Trypanosoma brucei rhodesiense infection of the white mouse.

Authors:  E Fink; H Schmidt
Journal:  Tropenmed Parasitol       Date:  1979-06

7.  Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.

Authors:  A Lourbakos; Y P Yuan; A L Jenkins; J Travis; P Andrade-Gordon; R Santulli; J Potempa; R N Pike
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

Review 8.  Microbial translocation of the blood-brain barrier.

Authors:  Kwang Sik Kim
Journal:  Int J Parasitol       Date:  2006-03-06       Impact factor: 3.981

9.  Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers.

Authors:  Jinho Park; Kyoung-Seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 10.  Protease-activated receptor signaling: new roles and regulatory mechanisms.

Authors:  Stephen F Traynelis; Joann Trejo
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

View more
  30 in total

Review 1.  The trypanosome flagellar pocket.

Authors:  Mark C Field; Mark Carrington
Journal:  Nat Rev Microbiol       Date:  2009-10-06       Impact factor: 60.633

2.  Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model.

Authors:  Johnson Nasimolo; Stephen Gitahi Kiama; Peter Karuri Gathumbi; Andrew Ndegwa Makanya; John Maina Kagira
Journal:  Metab Brain Dis       Date:  2014-01-23       Impact factor: 3.584

Review 3.  Parasite dissemination and the pathogenesis of toxoplasmosis.

Authors:  L M Randall; C A Hunter
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

4.  Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors.

Authors:  Wenlin Huang; Zhongsheng Zhang; Ranae M Ranade; J Robert Gillespie; Ximena Barros-Álvarez; Sharon A Creason; Sayaka Shibata; Christophe L M J Verlinde; Wim G J Hol; Frederick S Buckner; Erkang Fan
Journal:  Bioorg Med Chem Lett       Date:  2017-04-17       Impact factor: 2.823

5.  Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.

Authors:  Dennis J Grab; Jose C Garcia-Garcia; Olga V Nikolskaia; Yuri V Kim; Amanda Brown; Carlos A Pardo; Yongqing Zhang; Kevin G Becker; Brenda A Wilson; Ana Paula C de A Lima; Julio Scharfstein; J Stephen Dumler
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

6.  Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1.

Authors:  Paul Capewell; Nicola J Veitch; C Michael R Turner; Jayne Raper; Matthew Berriman; Stephen L Hajduk; Annette MacLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

7.  SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis.

Authors:  Robert T Jacobs; Bakela Nare; Stephen A Wring; Matthew D Orr; Daitao Chen; Jessica M Sligar; Matthew X Jenks; Robert A Noe; Tana S Bowling; Luke T Mercer; Cindy Rewerts; Eric Gaukel; Jennifer Owens; Robin Parham; Ryan Randolph; Beth Beaudet; Cyrus J Bacchi; Nigel Yarlett; Jacob J Plattner; Yvonne Freund; Charles Ding; Tsutomu Akama; Y-K Zhang; Reto Brun; Marcel Kaiser; Ivan Scandale; Robert Don
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

8.  Murine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropism.

Authors:  Christiane Giroud; Florence Ottones; Virginie Coustou; Denis Dacheux; Nicolas Biteau; Benjamin Miezan; Nick Van Reet; Mark Carrington; Felix Doua; Théo Baltz
Journal:  PLoS Negl Trop Dis       Date:  2009-09-01

9.  Immunophenotypic lymphocyte profiles in human african trypanosomiasis.

Authors:  Caroline Boda; Bertrand Courtioux; Pierre Roques; Lynda Pervieux; Gédéon Vatunga; Théophile Josenando; Constant Roger Ayenengoye; Bernard Bouteille; Marie-Odile Jauberteau; Sylvie Bisser
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

10.  Early invasion of brain parenchyma by African trypanosomes.

Authors:  Ute Frevert; Alexandru Movila; Olga V Nikolskaia; Jayne Raper; Zachary B Mackey; Maha Abdulla; James McKerrow; Dennis J Grab
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.